Individual differences in the reinforcing and subjective effects of amphetamine and diazepam☆
References (26)
- et al.
Drug Alcohol Depend.
(1984) - et al.
Pharmacol. Biochem. Behav.
(1983) - et al.
J. Pharmacol. Exp. Ther.
(1961) - et al.
Animal models of drug self-administration
- et al.
Psychopharmacology
(1980) - et al.
Psychopharmacology
(1980) The effects of two non-pharmacological variables on drug preference in humans
- H. de Wit et al., Arch. Gen. Psychiatry, in...
- et al.
Psychopharmacology
(1983) - et al.
Psychopharmacology
(1985)
J. Pharmacol
Exp. Ther.
Benzodiazepine self-administration in animals and humans: A comprehensive literature review
Cited by (178)
Methamphetamine, amphetamine, and aggression in humans: A systematic review of drug administration studies
2022, Neuroscience and Biobehavioral ReviewsHuman behavioral pharmacology of stimulant drugs: An update and narrative review
2022, Advances in PharmacologySubjective responses predict d-amphetamine choice in healthy volunteers
2021, Pharmacology Biochemistry and BehaviorCitation Excerpt :These studies found that healthy volunteers who experienced pleasant, stimulant-like subjective effects after d-amphetamine (5 or 10 mg) chose the drug (over placebo) on choice sessions (Chait, 1993; de Wit et al., 1986; Dlugos et al., 2011; Gabbay, 2003; Johanson et al., 1983). In two of the studies, a minority of subjects reported negative subjective effects: subjects who did not choose the amphetamine (i.e., chose placebo) reported that the drug increased anxiety and depression (de Wit et al., 1986; Gabbay, 2003). Thus, subjects who experience more positive effects are likely to choose the drug whereas those who experience negative effects choose the placebo.
Effect of Δ9-Tetrahydrocannabinol on frontostriatal resting state functional connectivity and subjective euphoric response in healthy young adults
2021, Drug and Alcohol DependenceCitation Excerpt :To assess subjective euphoric response to drug, participants completed the ARCI throughout the drug administration visit, including at baseline (0 min; prior to drug administration), 90 min (prior to the fMRI scan), and 180 min (after the fMRI scan). The Morphine–Benzedrine Group (MBG, euphoric effects) scale was used, as this has been shown to represent the positive, rewarding effects of drugs (e.g., de Wit et al., 1986; Fischman and Foltin, 1991). The peak change difference score for ARCI-MBG (peak score (average of 90 min and 180 min assessments) minus baseline (0 min) score; Mayo and de Wit, 2015) was used for analyses.
Stability of acute responses to drugs in humans across repeated testing: Findings with alcohol and amphetamine
2020, Drug and Alcohol Dependence
- ☆
This research was funded by NIDA grant DA-02812 awarded to C.E. Johanson.